|
1.IntroductionCardiovascular disease is a major cause of morbidity in developed Western countries. Vulnerable atherosclerotic plaque (VP) is an important topic in cardiology research, since patients with these unstable plaques are at great risk for a sudden heart attack (i.e., myocardial infarction) when a plaque suddenly ruptures. Rupture of the thin fibrous cap when its thickness is , and the resulting subsequent thrombotic occlusion, is the most common cause of death from vulnerable plaque. Finding criteria to identify and measure the degree of risk from these lesions is an active area of investigation.1–6 Studies have also shown that a high degree of vulnerable plaque atherosclerosis is a significant indicator of coronary artery disease.7–9 Clinically, there are several diagnostic tools, e.g., x-ray angiography, angioscopy, nuclear scintigraphy, and magnetic resonance imaging that are used for identifying the luminal diameter of the aorta and arterial stenosis. However, there are only a few studies that have been performed using Raman spectroscopy and the vibrational frequencies of lipids for detecting atherosclerotic diseases and the thicknesses of cap layers on VPs.10–16 None of these studies used resonance Raman (RR). Optical biopsy techniques, such as label-free native fluorescence, Raman spectroscopy, and optical imaging for in vivo cancer detection in human tissues and cells, have been advanced significantly since 1984 by Alfano’s group.17–19 In our previous studies using 532-nm excitation for RR on human brain, breast, gynecological, gastrointestinal, and atherosclerotic abdominal aortic tissues studies,16,20–24 the RR spectra in vitro exhibited native molecular signatures that could be used as optical histopathological criteria to distinguish normal from abnormal tissues. The 532-nm wavelength is a newly important finding for tissue to generate extraordinarily large Raman signals that are useful for quasireal-time measurements. Statistical methods, such as principal component analysis and support vector machine, were used to analyze the RR spectral data collected from benign tumors, cancerous tumors, and normal breast tissues, as well as from meningiomas, benign tumors, and normal meningeal brain tissues. These methods yielded a diagnostic sensitivity of 90.9% and a specificity of 100%.20–21 Reports detailing the use of the RR technique for studying cardiovascular disease are very limited. One early report on RR scattering spectra in human breast and lung tissues was published by Alfano et al.25 for the first time. RR scattering spectra for cardiovascular tissue were first reported by Clarke et al.10 In this work, the authors observed strong RR features from the calcific deposits within the coronary artery and in the aortic valve. They showed a typical Raman spectrum from a fatty plaque within the human coronary artery obtained with a 514.5-nm laser excitation. Three strong peaks dominated the RR spectra at 1006, 1156, and .11 The results of other studies on the near-infrared (NIR) and Fourier-transform (NIR-FT) Raman spectroscopy by Rava et al.12 and by Feld’s group13,14,26,27 have been used to identify and evaluate human atherosclerotic and vulnerable plaque lesions. These studies described a morphological model for the simultaneous changes in biochemical components, which provided information on different stages of arterial lesions. However, those results were only in the lower frequency spectral region of 750 to .12–15,26,27 This report focuses on the visible RR (VRR) technique for directly distinguishing and classifying vulnerable plaques with various states of atherosclerosis development and different cap thicknesses in human aorta tissues using RR spectral molecular fingerprints in a wide frequency region. 2.Methods and Materials2.1.MethodsAll RR spectra were collected directly from a region of interest along multiple sites on each specimen. The original RR spectrographs, without subtracting for the baseline of light, were produced using WITec Project 2.10 and ORIGIN 2015 software. The Raman spectra were collected from the four specimens shown in Fig. 1, referred to as FAT, M1, M2, and R1. The numbers superimposed on the specimens indicate the sites where spectra were collected and the fibrous cap thicknesses were examined by standard histopathology (Figs. 1 and 2). The histopathology analysis indicated that arteries had extensive calcification and ossification. Thus measurements were made from the edge of the fibrous cap to the beginning of the calcification. Each sample was placed on the stage of the WITec alpha 300R microconfocal Raman and imaging system as has been described in detail previously.16 The final spectral resolution was in the range of 400 to . 2.2.Human Tissue SampleRR spectra of human aorta samples with different states of tissues, including normal fat from the adventitial side arterial wall and three pieces of atherosclerotic plaques lesions, were recorded using a confocal micro-Raman spectrometer. Thirty nine RR spectra were collected from four aortic samples and analyzed. In the RR spectra, a small NIR wing was observed at higher frequencies. The human aorta specimens exhibiting varying calcific deposits of atherosclerotic vulnerable plaques disease were obtained from the National Disease Research Interchange (NDRI, Philadelphia, Pennsylvania). Some of the tissues exhibited extensive calcification and, in some cases, showed ossification. The experimental procedures were approved by the City College of the City University of New York, Institutional Review Board (IRB) office. The 12-cm long aorta specimen (Fig. 1, “A”) was dissected longitudinally and then cut into four irregularly shaped size pieces as shown in Fig. 1 and marked FAT, M1, M2, and R1. The aorta specimen was obtained from a 92-year-old female with hypercholesterolemia who died from respiratory arrest. The patient had a history of hypertension but no history of diabetes. In general, we used about 200 samples of atherosclerotic abdominal aortic tissues and cells. The samples size ranged from microns to centimeters. 3.Experimental Results and DiscussionsThe patterns of RR peaks in the spectra collected from different positions (Fig. 1) on the intimal aortic wall lesions correlate with the disease process as it progresses through the development of arterial fibrolipid plaques, VPs, and calcification and ossification. RR spectra collected from the four laboratory grade samples, including normal fats, chemicals (pure cholesterol powder, HDL, and LDL) (Fig. 3), and three states of atherosclerotic lesions in aortic tissues are shown in Fig. 4. 3.1.Laboratory Grade SamplesFigure 3 shows RR spectra from three materials that will help assign peaks in the spectra from the aortic samples (Fig. 4) to specific compounds. Figure 3(a) shows the RR spectrum of pure cholesterol powder, Fig. 3(b) shows the RR spectrum of fat from the tunica adventitial aorta (Fig. 1, “A” marked as FAT). Figure 3(c) shows the RR spectra of liquid HDL and LDL obtained from human plasma. Figures 3(a)–3(c) highlight the characteristic RR peaks due to cholesterol (located at 704, 1440, and ), to carotenoids (located at 1007, 1157, and ), and to the methylene group [] vibrational mode and methyl group [] (located at 2854, 2895, and ).28,29 3.2.Fibrolipid PlaquesThe RR spectrum, collected from the sample site numbered M2-07, is shown in Fig. 4(a). Similar RR spectral profiles of M1-02 and R-11 are not shown. A comparison of the spectrum shown in Fig. 4(a) to the RR spectra in Fig. 3 reveals that the Raman peaks common to both spectra are at 1012, 1161, and . This suggests an assignment for fatty plaque that is close to that of the lipids in aortic tissue [Figs. 3(b) and 3(c)] and, therefore, is likely to be atherosclerotic aortic tissue.11 Lesions in the sites M2-07, M1-02, and R-11 can be considered as representing an early state of the disease process, a noncalcified atherosclerotic fibrolipid plaque whose RR spectrum contains three distinguishable vibrational modes at 1517, 1161, and arising from intense RR lines of carotenoid molecules. These frequencies have been assigned to vibrational modes of the carotene conjugated polyene backbone, and the vibrational mode assigned to aromatic amino acids molecules, tryptophan, and phenylalanine. The weak small peak occurring at can be attributed to the initial calcification of early stage plaque lesions. In these lesion sites, a second set of Raman spectral molecular fingerprints arises from the macromolecules of lipids and lipoproteins.30 These characteristic vibrational modes are at 2854, 2892, and , as shown in all three spectra in Fig. 3. Key differences in these peaks are seen in the spectra obtained from normal aortic fat tissue and fibrolipid atherosclerotic plaque tissue.11,12,14–16 For example, as shown in Figs. 3(a) and 3(b), in HDL/LDL powder and normal aortic fat, the presence of a sharp methylene () peak is observed at . Additionally, the characteristic band of spectral peaks observed at 2932 (Fermi resonance of a mode) and was attributed to the vibrations of methylene (Fermi resonance of a mode) groups. However, in noncalcified atherosclerotic fibrolipid plaque tissue [Fig. 4(a)], the Raman spectral peak at is greatly diminished, while the other two distinct Raman spectral peaks of lipid and lipoproteins at 2895 and decayed greatly. The changes in peak intensity and position in the Raman spectral profiles indicate an important finding. These two characteristics provide a signal to track the transformation of the composition and protein conformation in the cells, as well as the changes in the molecular structure of fibrolipid plaque lesion tissues.31 3.3.Vulnerable Atherosclerotic PlaquesFigure 4(b) shows a typical spectrum for another type of atherosclerotic plaque, obtained from the R1-03 site (and similar to the RR spectra of R1-04 and M1-01, which are not shown). The three salient characteristics of Raman spectra in this type are: (1) a large lipid pool that has distinct lipid Raman peaks at 2888, 1678, and , with a peak at that possibly arises from calcified fragments of extracellular debris in ruptured plaque. (2) The enhanced amide III mode at for these type lesions has no shift in its peak position. The sharp intense stable marker at can be interpreted as an independent fingerprint. It represents the breathing mode, which gives the most information about the status of red blood cells, as well as direct measures of the heme group in hemoglobin. It is also a characteristic peak of tryptophan, but it is intense and it changes in intensity with the state of atherosclerotic plaques, suggesting that its origin is from heme groups. (3) The intense resonance enhancements of the Raman spectra were displayed in three groups of peaks: (a) one group at 1131 to and a sharp intense peak at that arose from the fatty acid (i.e., lipid assignment). The significant peak shifts in proteins were observed: , at , in which the carotenoid was not in normal tissue; , where the in-plane bending mode of tyrosine (collagen type I) was present; and 1173 and , which are the peaks due to tyrosine, phenylalanine, and the bend (protein). These spectral profile changes and peak position shifts reflect molecular structure changes corresponding to the difference in fibrous cap thickness. For example, the R1-03 site has a VP cap thickness of and the R1-04 site has a similar thickness of , both of which are thinner than the thickness that defines a highly unstable thin cap fibroatheroma (TCFA) plaque. Data points for both of these samples are included in Fig. 5 and R1-03 is shown in Fig. 2. (b) The second group between 1316 to represents several remarkable modes: depicts the G (ring breathing modes of the DNA/RNA bases) deformation (protein) and amide III (-helix), shows the contribution of T, A, G (ring breathing modes of the DNA/RNA, bases-protein), and tryptophan. (c) The third group, between 1554 and , contains modes which are marked by the following peaks: the peak from the protein amide II, which was derived mainly from the in-plane bending, the peak indicates the stretching and phosphate () symmetric stretching vibrational mode, which is a characteristic of nucleic acids, as well as a known mode for tryptophan, and the peak that is due to the stretching and bending in phenylalanine and tyrosine.32–35 These three distinct groups consist mainly of enhanced Raman peaks for proteins, which suggests that the 532-nm excitation wavelength matched (or closely matched) the molecular absorption wavelengths for compounds in the cells and tissues. For example, the metalloprotein, hemoglobin, has one absorption band at 534 nm. Similarly, the mitochondrial electron transport protein, cytochrome C, has one absorption wavelength at 552 nm (under hypoxia conditions) or the two-photon absorption process under RR conditions that may allow the R1, M1, and M2 sites of the ruptured plaque processes to be seen.32 RR peaks associated with proteins on the molecular level in ruptured fibrolipid plaques tissues were shown and thought to be due to heme proteins, such as the cytochromes that reside in the mitochondria. These RR spectra from arterial sites may reveal the processes of plaque rupture or thrombosis. At these positions (R1-03, R1-04, and M1-01), lesions may be classified as advanced in the clinical stage. This is because we found (a) ruptured atherosclerotic plaques with surface erosions, hemorrhages, and thrombus at the test site, as can be seen in the image labeled Fig. 4(b) and column 5 in Fig. 2; (b) the fibrous cap thickness at the tested location on the sample (column 4 of Fig. 2) is a very thin , as measured by histopathology; and (c) the RR spectrum at tested site R1-03 in Fig. 5 showed enhanced RR peaks from collagen and fibro muscular tissue layers covering the extracellular lipid pool at 1456, 1554, 1640, and indicating that the plaque has progressed to the clinically silent and advanced stage.14,26 3.4.Calcified and Ossified PlaquesFigure 4(c) shows a typical RR spectrum for the third set of lesions where calcification has evolved into ossification. In the highly calcified deposits on the atherosclerotic plaques and ossified lesion, the featured vibrational mode is a sharp peak at with a weaker band at that arises from the symmetric stretching vibration of , calcium-phosphate stretch band (contains high quantities of cholesterol), and a phosphate symmetric stretching vibration of calcium hydroxyapatite (HA) and quinoid ring in-plane deformation. In addition, the band arose from the symmetric stretching vibration of [phosphate of (HA)-single phase HA], or , and phospholipids. In this set of lesions, all the characteristic Raman peaks of lipids and proteins, which appeared in Figs. 4(a) and 4(c), were decayed and diminished. This indicates that, in this state, the main components may be crystalline cholesterol, cholesteryl esters, and phospholipids.13,15,16,28 3.5.Fibrous Cap ThicknessThe RR spectra in different types of atherosclerotic plaque are clearly correlated to the changes of VP fibrous cap thickness as measured by standard histopathology methods and shown in Figs. 2 and 5. The signal-to-noise ratio of the peak intensity at for two classes of plaques varies exponentially with fibrous cap thickness (Fig. 5), but with different exponential decay rates. The samples with small fibrous cap thicknesses exhibit one rate of exponential decay, while those with thicker caps exhibit a much smaller decay rate. This suggest two different cap morphologies for the two types of plaques since the morphology will determine the opacity of the cap to the RR scattered light from the lipid pool and, therefore, the decay rate. The two decay curves intersect near the cap thickness value of . This value is very close to the conventional TCFA definition of .36,37 The result in Fig. 5 is attributed to the transition from ballistic photons propagating through thin caps to diffusive photons propagating through a thicker cap, which occurs at .38 Confirmation of the importance of this finding is left for future work but it suggests that RR measurements of cap thickness can be used to detect the presence of a highly unstable TCFA plaque. Figure 2 shows a comparison of normal arterial fat tissue versus three types lesions of atherosclerotic plaques corresponding to their RR spectra, histopathology images (Fig. 2, column 3), fibrous cap thickness, and the confocal microscopy photographs (Fig. 2, columns 4 and 5). Table 1 lists the vibrational assignments of the modes. Table 1Human atherosclerosis aortic specimens obtained from NDRI selected RR spectral peak position and assignment of specimen tissues.
Note: s, strong; vs, very strong; w, weak; vw, very weak; and m, medium. 4.ConclusionCommon Raman system detection techniques usually cannot generate enhanced resonance molecular Raman lines and high resolution. In this study, e.g., the protein line in the amide II active line at , carotene lines at 1161 and , amino acid tryptophan lines at 1589 and , and the intense resonance enhancement in the three groups of peaks [shown in Fig. 4(b)] suggest that the 532-nm excitation wavelength matched (or closely matched) the absorption wavelengths for molecular compounds in the cells and tissues. The VRR system also has the advantage of requiring less power and accumulation time to collect signals, compared with NIR or FT-Raman systems.12–15 In conclusion, we have successfully demonstrated that the changes in components and conformation of three states of VPs identified using RR molecular fingerprints and the vibrational mode can be detected and identified for lipids that are under the thin intimal wall of the plaque’s cap region. The RR spectral findings revealed that these molecular fingerprints can identify the vascular calcification process of atherosclerosis and may provide higher accuracy and sensitivity. The outcomes of these research findings are:
DisclosuresThe authors report grants from National Institutes of Health (NIH), during the conduct of the study. In addition, the authors have a patent “Raman and Resonant Raman Detection of Vulnerable Plague Optical Analyzer and Imager” pending. AcknowledgmentsThis work was supported in part by Energy Research Co. from NIH (National Heart, Lung, and Blood Institute of the NIH under Award No. R41HL126568). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors are grateful to Dr. K. Sutkus and Dr. Lin Zhang for the assistance with paper preparation and submission. Use of human subjects and animals: In this study, the human aorta specimens were obtained from the NDRI, Philadelphia, Pennsylvania. The experimental procedures were approved by the City College of the City University of New York, IRB office. ReferencesZ. A. Fayad and V. Fuster,
“Clinical imaging of the high-risk or vulnerable atherosclerotic plaque,”
Circ. Res., 89 305
–316
(2001). http://dx.doi.org/10.1161/hh1601.095596 CIRUAL 0009-7330 Google Scholar
L. C. Hofbauer et al.,
“Vascular calcification and osteoporosis—from clinical observation towards molecular understanding,”
Osteoporosis Int., 18 251
–259
(2007). http://dx.doi.org/10.1007/s00198-006-0282-z OSINEP 1433-2965 Google Scholar
M. R. Hayden et al.,
“Vascular ossification–calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis–calcific uremic arteriolopathy: the emerging role of sodium thiosulfate,”
Cardiovasc. Diabetol., 4 4
(2005). http://dx.doi.org/10.1186/1475-2840-4-4 Google Scholar
G. A. Rodríguez-Granillo et al.,
“New insights towards catheter-based identification of vulnerable plaque,”
Rev. Esp. Cardiol., 58 1197
–1206
(2005). http://dx.doi.org/10.1157/13079914 Google Scholar
G. P. Fazio et al.,
“Transesophageal echocardiographically detected atherosclerotic aortic plaque is a marker for coronary artery disease,”
J. Am. Coll. Cardiol., 21 144
–150
(1993). http://dx.doi.org/10.1016/0735-1097(93)90729-K JACCDI 0735-1097 Google Scholar
E. R. Mohler et al.,
“Bone formation and inflammation in cardiac valves,”
Circulation, 103 1522
–1528
(2001). http://dx.doi.org/10.1161/01.CIR.103.11.1522 Google Scholar
A. C. van der Wal et al.,
“Atherosclerotic plaque rupture—pathologic basis of plaque stability and instability,”
Cardiovasc. Res., 41 334
–344
(1999). http://dx.doi.org/10.1016/S0008-6363(98)00276-4 CVREAU 0008-6363 Google Scholar
B. D. MacNeill et al.,
“Intravascular modalities for detection of vulnerable plaque: current status,”
Arterioscler. Thromb. Vasc. Biol., 23 1333
–1342
(2003). http://dx.doi.org/10.1161/01.ATV.0000080948.08888.BF ATVBFA 1079-5642 Google Scholar
S. W. E. van de Poll et al.,
“On-line detection of cholesterol and calcification by catheter based Raman spectroscopy in human atherosclerotic plaque ex vivo,”
Heart, 89 1078
–1082
(2003). http://dx.doi.org/10.1136/heart.89.9.1078 Google Scholar
R. H. Clarke et al.,
“Laser Raman spectroscopy of calcified atherosclerotic lesions in cardiovascular tissue,”
Appl. Opt., 26 3175
(1987). http://dx.doi.org/10.1364/AO.26.003175 APOPAI 0003-6935 Google Scholar
R. H. Clarke, Q. Wang and J. M. Isner,
“Laser Raman spectroscopy of atherosclerotic lesions in human coronary artery segments,”
Appl. Opt., 27 4799
(1988). http://dx.doi.org/10.1364/AO.27.004799 APOPAI 0003-6935 Google Scholar
R. P. Rava, J. J. Baraga and M. S. Feld,
“Near infrared Fourier transform Raman spectroscopy of human artery,”
Spectrochim. Acta Part A, 47 509
–512
(1991). http://dx.doi.org/10.1016/0584-8539(91)80129-7 Google Scholar
J. J. Baraga, M. S. Feld and R. P. Rava,
“In situ optical histochemistry of human artery using near infrared Fourier transform Raman spectroscopy,”
Proc. Natl. Acad. Sci. U. S. A., 89 3473
–3477
(1992). http://dx.doi.org/10.1073/pnas.89.8.3473 Google Scholar
J. T. Motz et al.,
“In vivo Raman spectral pathology of human atherosclerosis and vulnerable plaque,”
J. Biomed. Opt., 11 021003
(2006). http://dx.doi.org/10.1117/1.2190967 JBOPFO 1083-3668 Google Scholar
G. V. Nogueira et al.,
“Raman spectroscopy study of atherosclerosis in human carotid artery,”
J. Biomed. Opt., 10 031117
(2005). http://dx.doi.org/10.1117/1.1908129 JBOPFO 1083-3668 Google Scholar
C. Liu et al.,
“Optical pathology study of human abdominal aorta tissues using confocal micro resonance Raman spectroscopy,”
Proc. SPIE, 9703 97031S
(2016). http://dx.doi.org/10.1117/12.2213368 Google Scholar
R. Alfano et al.,
“Laser induced fluorescence spectroscopy from native cancerous and normal tissue,”
IEEE J. Quantum Electron., 20 1507
–1511
(1984). http://dx.doi.org/10.1109/JQE.1984.1072322 IEJQA7 0018-9197 Google Scholar
M. Jermyn et al.,
“Intraoperative brain cancer detection with Raman spectroscopy in humans,”
Sci. Transl. Med., 7 274ra19
(2015). http://dx.doi.org/10.1126/scitranslmed.aaa2384 STMCBQ 1946-6234 Google Scholar
M. S. Bergholt et al.,
“Fiberoptic confocal Raman spectroscopy for real-time in vivo diagnosis of dysplasia in Barrett’s esophagus,”
Gastroenterology, 146 27
–32
(2014). http://dx.doi.org/10.1053/j.gastro.2013.11.002 Google Scholar
Y. Zhou et al.,
“Human brain cancer studied by resonance Raman spectroscopy,”
J. Biomed. Opt., 17 116021
(2012). http://dx.doi.org/10.1117/1.JBO.17.11.116021 JBOPFO 1083-3668 Google Scholar
C.-H. Liu et al.,
“Resonance Raman and Raman spectroscopy for breast cancer detection,”
Technol. Cancer Res. Treat., 12 371
–382
(2013). http://dx.doi.org/10.7785/tcrt.2012.500325 Google Scholar
Y. Zhou et al.,
“Tumor margin detection using optical biopsy techniques,”
Proc. SPIE, 8940 894014
(2014). http://dx.doi.org/10.1117/12.2038723 PSISDG 0277-786X Google Scholar
Y. Zhou et al.,
“Brain metastasis detection by resonant raman optical biopsy method,”
Proc. SPIE, 8940 89400C
(2014). http://dx.doi.org/10.1117/12.2038731 Google Scholar
Y. Zhou et al.,
“Resonant Raman spectra of grades of human brain glioma tumors reveal the content of tryptophan by the mode,”
Proc. SPIE, 9318 931810
(2015). http://dx.doi.org/10.1117/12.2079458 PSISDG 0277-786X Google Scholar
R. Alfano et al.,
“Fluorescence spectra from cancerous and normal human breast and lung tissues,”
IEEE J. Quantum Electron., 23 1806
–1811
(1987). http://dx.doi.org/10.1109/JQE.1987.1073234 IEJQA7 0018-9197 Google Scholar
H. P. Buschman et al.,
“Raman microspectroscopy of human coronary atherosclerosis: biochemical assessment of cellular and extracellular morphologic structures in situ,”
Cardiovasc. Pathol., 10 69
–82
(2001). http://dx.doi.org/10.1016/S1054-8807(01)00064-3 CATHE8 1054-8807 Google Scholar
T. J. Romer et al.,
“Histopathology of human coronary atherosclerosis by quantifying its chemical composition with Raman spectroscopy,”
Circulation, 97 878
–885
(1998). http://dx.doi.org/10.1161/01.CIR.97.9.878 Google Scholar
O. Mermut et al.,
“Directions in peptide interfacial science,”
Biointerphases, 1 P5
–P11
(2006). http://dx.doi.org/10.1116/1.2194033 Google Scholar
R. M. Kubba, S. H. Rida and A. H. Hanoon,
“Vibration frequencies, normal coordinates and IR absorption intensities of 1-; 1, 2-Di-; 1, 3-Di- and 1, 2, 3-trimethylene cyclobutane,”
Z. Naturforsch. A., 60 411
–418
(2005). http://dx.doi.org/10.1515/zna-2005-0605 Google Scholar
M. Ji et al.,
“Rapid, label-free detection of brain tumors with stimulated Raman scattering microscopy,”
Sci. Transl. Med., 5 201ra119
(2013). http://dx.doi.org/10.1126/scitranslmed.3005954 STMCBQ 1946-6234 Google Scholar
N. Haspel et al.,
“Tracing conformational changes in proteins,”
BMC Struct. Biol., 10 S1
(2010). http://dx.doi.org/10.1186/1472-6807-10-S1-S1 Google Scholar
S. Pripotnev et al.,
“UV resonance Raman spectroscopy probes the amide II’p band position in short breast milk peptides with antioxidant activity,”
J. Raman Spectrosc., 42 2105
–2111
(2011). http://dx.doi.org/10.1002/jrs.v42.12 JRSPAF 0377-0486 Google Scholar
F. Adar and M. Erecinska,
“Photoreductive titration of the resonance Raman spectra of cytochrome oxidase in whole mitochondria,”
Biochemistry, 18 1825
–1829
(1979). http://dx.doi.org/10.1021/bi00576a030 Google Scholar
M. G. F. Sharp et al.,
“Differential expression of the mitochondrial gene cytochrome oxidase II in benign and malignant breast tissue,”
J. Pathol., 168 163
–168
(1992). http://dx.doi.org/10.1002/(ISSN)1096-9896 Google Scholar
J. M. Steinke and A. P. Shepherd,
“Effects of temperature on optical absorbance spectra of oxy-, carboxy-, and deoxyhemoglobin,”
Clin. Chem., 38 1360
–1364
(1992). Google Scholar
A. P. Burke et al.,
“Coronary risk factors and plaque morphology in men with coronary disease who died suddenly,”
N. Engl. J. Med., 336 1276
–1282
(1997). http://dx.doi.org/10.1056/NEJM199705013361802 NEJMAG 0028-4793 Google Scholar
M. Nakano et al., Coronary Heart Disease, 187
–197 Springer, New York
(2012). Google Scholar
L. Wang et al.,
“Ballistic 2-D imaging through scattering walls using an ultrafast optical Kerr gate,”
Science, 253 769
–771
(1991). http://dx.doi.org/10.1126/science.253.5021.769 SCIEAS 0036-8075 Google Scholar
Z. Movasaghi, S. Rehman and I. U. Rehman,
“Raman spectroscopy of biological tissues,”
Appl. Spectrosc. Rev., 42 493
–541
(2007). http://dx.doi.org/10.1080/05704920701551530 APSRBB 0570-4928 Google Scholar
|